董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Hadar Ron | 女 | Director, Interim Chair of the Board | 67 | 未披露 | 5.73 | 2026-05-19 |
| Moshe Mizrahy | 男 | Chief Executive Officer and Director | 73 | 21.60万美元 | 349.92 | 2026-05-19 |
| Michael Kreindel | 男 | Chief Technology Officer and Director | 59 | 26.70万美元 | 311.48 | 2026-05-19 |
| Nadav Kenneth | 男 | Director | 66 | 未披露 | 0.15 | 2026-05-19 |
| Shlomo Nass | 男 | Independent Director | 66 | 未披露 | 未持股 | 2026-05-19 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Moshe Mizrahy | 男 | Chief Executive Officer and Director | 73 | 21.60万美元 | 349.92 | 2026-05-19 |
| Michael Kreindel | 男 | Chief Technology Officer and Director | 59 | 26.70万美元 | 311.48 | 2026-05-19 |
| Michael Dennison | 男 | President, North America | 45 | 199.90万美元 | 1.05 | 2026-05-19 |
| Moshe Itzkovich | 男 | Chief Financial Officer | 41 | 未披露 | 未持股 | 2026-05-19 |
董事简历
中英对照 | 中文 | 英文- Hadar Ron
-
Hadar Ron于2019年8月成为InMode Ltd.公司董事。自2000年以来，Ron博士一直是以色列生命科学风险投资基金Israel Healthcare Ventures的创始和管理合伙人。Ron博士还是以色列生命科学风险投资基金Israel Healthcare Ventures 2 LPIncorporated（IHCV2）管理公司的首席执行官。Ron博士担任专门从事结肠直肠筛查的医疗器械公司G.I. View Ltd.和信息技术初创公司CyTwist Ltd.的董事长，并担任以下公司的董事会成员：Home Skinovations Ltd.、SipNose Ltd.、Pet Novations Ltd.、Peri-Ness Technologies Ltd.、Viroblock Ltd.、O.G.D.H. Ltd.、OrSense Ltd.和NanoPass Technologies Ltd.。此外，Ron博士担任Together Pharma Ltd.的外部董事。此外，Ron博士还担任Momentum Fund的艾瑞博德成员，Momentum Fund是特拉维夫大学技术转让研究中心的成员，也是Birad Ltd的董事会成员，Bar Ilan大学的技术转让公司，也是以色列社会金融协会预防糖尿病和结肠癌的社会影响债券科学顾问委员会的主席。Ron医生是一名医生和受过教育的律师。她拥有特拉维夫大学的医学博士和法学博士学位，并曾在特拉维夫大学工商管理学院学习。
Hadar Ron became a director of the Company in August 2019. Since 2000, Dr. Ron has been the founding and managing partner of Israel Healthcare Ventures, an Israeli life science venture capital fund. Dr. Ron is also the chief executive officer of the management company for Israel Healthcare Ventures 2 LP Incorporated, or IHCV2, an Israeli life sciences venture capital fund. Dr. Ron serves as chairperson of G.I. View Ltd., a medical device company specializing in colorectal screenings, and Neurohelp Ltd., a Neurotechnology start up company, and as a board member of the following companies: Home Skinovations Ltd. (under voluntary liquidation), SipNose Ltd. (under voluntary liquidation), Pet Novations Ltd., Peri Ness Technologies Ltd., O.G.D.H. Ltd., OrSense Ltd., and Unbox Ventures Ltd. In addition, Dr. Ron serves as an external director of Together Pharma Ltd. In addition, Dr. Ron serves as a member of the advisory board of the Momentum Fund Tech Transfer of Tel Aviv University, a board member of BIRAD Ltd., the tech transfer company of Bar Ilan University, and is the chairperson of the scientific advisory board of Social Finance Israel's Social Impact Bond for the prevention of diabetes and colon cancer. Dr. Ron is a physician and attorney by education. She holds M.D. and L.L.B. degrees from Tel Aviv University and has studied at the School of Biness Administration at Tel Aviv University. - Hadar Ron于2019年8月成为InMode Ltd.公司董事。自2000年以来，Ron博士一直是以色列生命科学风险投资基金Israel Healthcare Ventures的创始和管理合伙人。Ron博士还是以色列生命科学风险投资基金Israel Healthcare Ventures 2 LPIncorporated（IHCV2）管理公司的首席执行官。Ron博士担任专门从事结肠直肠筛查的医疗器械公司G.I. View Ltd.和信息技术初创公司CyTwist Ltd.的董事长，并担任以下公司的董事会成员：Home Skinovations Ltd.、SipNose Ltd.、Pet Novations Ltd.、Peri-Ness Technologies Ltd.、Viroblock Ltd.、O.G.D.H. Ltd.、OrSense Ltd.和NanoPass Technologies Ltd.。此外，Ron博士担任Together Pharma Ltd.的外部董事。此外，Ron博士还担任Momentum Fund的艾瑞博德成员，Momentum Fund是特拉维夫大学技术转让研究中心的成员，也是Birad Ltd的董事会成员，Bar Ilan大学的技术转让公司，也是以色列社会金融协会预防糖尿病和结肠癌的社会影响债券科学顾问委员会的主席。Ron医生是一名医生和受过教育的律师。她拥有特拉维夫大学的医学博士和法学博士学位，并曾在特拉维夫大学工商管理学院学习。
- Hadar Ron became a director of the Company in August 2019. Since 2000, Dr. Ron has been the founding and managing partner of Israel Healthcare Ventures, an Israeli life science venture capital fund. Dr. Ron is also the chief executive officer of the management company for Israel Healthcare Ventures 2 LP Incorporated, or IHCV2, an Israeli life sciences venture capital fund. Dr. Ron serves as chairperson of G.I. View Ltd., a medical device company specializing in colorectal screenings, and Neurohelp Ltd., a Neurotechnology start up company, and as a board member of the following companies: Home Skinovations Ltd. (under voluntary liquidation), SipNose Ltd. (under voluntary liquidation), Pet Novations Ltd., Peri Ness Technologies Ltd., O.G.D.H. Ltd., OrSense Ltd., and Unbox Ventures Ltd. In addition, Dr. Ron serves as an external director of Together Pharma Ltd. In addition, Dr. Ron serves as a member of the advisory board of the Momentum Fund Tech Transfer of Tel Aviv University, a board member of BIRAD Ltd., the tech transfer company of Bar Ilan University, and is the chairperson of the scientific advisory board of Social Finance Israel's Social Impact Bond for the prevention of diabetes and colon cancer. Dr. Ron is a physician and attorney by education. She holds M.D. and L.L.B. degrees from Tel Aviv University and has studied at the School of Biness Administration at Tel Aviv University.
- Moshe Mizrahy
-
Moshe Mizrahy于2008年共同创立了该公司，自成立以来一直担任我们的首席执行官兼董事会主席。在此之前，Mizrahy先生是Syneron MedicalLtd.公司（一家位于以色列的医疗美容设备公司）的联合创始人兼首席执行官。Mizrahy先生也是Home Skinovations Ltd.的前首席执行官，该公司是一家活跃于家庭使用市场的国际医疗美容消费设备公司，目前自2007年起担任其董事会主席。除Home Skinovations Ltd.外，Mizrahy先生目前担任以下公司的董事会成员:Sipnose Ltd.、Pet Novations Ltd.、Peri-ness Technologies Ltd.、Easy-Lap Ltd、O.B.-Tools Ltd.、Urifer Ltd.、Easy Notes Ltd.、Escape Rescue Systems Ltd.、New Forest Wood Products-2012Ltd.，M.N.Business Strategy Ltd.、Himalaya Family Office Advisory Ltd.和Polimer Logistics Israel Ltd.Mizrahy先生在特拉维夫大学（Tel Aviv University）获得工程学学士学位，并在纽约佩斯大学（Pace University）获得工商管理硕士学位。
Moshe Mizrahy has served as a member of Xenetic Biosciences, Inc.'s Board since December 2023. Mr. Mizrahy is co founder of InMode Ltd. (NASDAQ: INMD) and has served as its Chief Executive Officer and Chairman of its board of directors since its inception in 2008. Prior to that, Mr. Mizrahy was co founder and chief executive officer of Syneron Medical Ltd. Mr. Mizrahy was also the former chief executive officer of Home Skinovations Ltd., and is currently chairman of its board. In addition to Home Skinovations Ltd., Mr. Mizrahy currently sits on the board of directors of SipNose Ltd., Pet Novations Ltd., Peri Ness Technologies Ltd., Santersus AG, Easy Lap Ltd., O.B. Tools Ltd., Urifer Ltd., Easy Notes Ltd., Escape Rescue Systems Ltd., M.N. Business Strategy Ltd., Silk'n Cure Ltd., Himalaya Family Office Advising Ltd. and Polimer Logistics (Israel) Ltd. Mr. Mizrahy is co founder and general partner of Nitzanim AVX Kyocera Venture Capital Fund and First Israel Mezzeine Investors Fund. Mr. Mizrahy has expertise in value creation for medical technologies, fundraising, public offerings, marketing and regulatory affairs. Mr. Mizrahy has a B.S. in Engineering from the Tel Aviv University and an MBA from Pace University, New York. - Moshe Mizrahy于2008年共同创立了该公司，自成立以来一直担任我们的首席执行官兼董事会主席。在此之前，Mizrahy先生是Syneron MedicalLtd.公司（一家位于以色列的医疗美容设备公司）的联合创始人兼首席执行官。Mizrahy先生也是Home Skinovations Ltd.的前首席执行官，该公司是一家活跃于家庭使用市场的国际医疗美容消费设备公司，目前自2007年起担任其董事会主席。除Home Skinovations Ltd.外，Mizrahy先生目前担任以下公司的董事会成员:Sipnose Ltd.、Pet Novations Ltd.、Peri-ness Technologies Ltd.、Easy-Lap Ltd、O.B.-Tools Ltd.、Urifer Ltd.、Easy Notes Ltd.、Escape Rescue Systems Ltd.、New Forest Wood Products-2012Ltd.，M.N.Business Strategy Ltd.、Himalaya Family Office Advisory Ltd.和Polimer Logistics Israel Ltd.Mizrahy先生在特拉维夫大学（Tel Aviv University）获得工程学学士学位，并在纽约佩斯大学（Pace University）获得工商管理硕士学位。
- Moshe Mizrahy has served as a member of Xenetic Biosciences, Inc.'s Board since December 2023. Mr. Mizrahy is co founder of InMode Ltd. (NASDAQ: INMD) and has served as its Chief Executive Officer and Chairman of its board of directors since its inception in 2008. Prior to that, Mr. Mizrahy was co founder and chief executive officer of Syneron Medical Ltd. Mr. Mizrahy was also the former chief executive officer of Home Skinovations Ltd., and is currently chairman of its board. In addition to Home Skinovations Ltd., Mr. Mizrahy currently sits on the board of directors of SipNose Ltd., Pet Novations Ltd., Peri Ness Technologies Ltd., Santersus AG, Easy Lap Ltd., O.B. Tools Ltd., Urifer Ltd., Easy Notes Ltd., Escape Rescue Systems Ltd., M.N. Business Strategy Ltd., Silk'n Cure Ltd., Himalaya Family Office Advising Ltd. and Polimer Logistics (Israel) Ltd. Mr. Mizrahy is co founder and general partner of Nitzanim AVX Kyocera Venture Capital Fund and First Israel Mezzeine Investors Fund. Mr. Mizrahy has expertise in value creation for medical technologies, fundraising, public offerings, marketing and regulatory affairs. Mr. Mizrahy has a B.S. in Engineering from the Tel Aviv University and an MBA from Pace University, New York.
- Michael Kreindel
-
Michael Kreindel于2008年共同创立了该公司，并自成立以来一直担任我们的首席技术官。Kreindel博士于2019年8月成为公司董事。他曾于2001年至2007年担任Syneron MedicalLtd.的联合创始人和首席技术官。Kreindel博士拥有物理学和数学博士学位，也毕业于俄罗斯乌拉尔理工大学（Ural Politechnical Institute），担任实验和理论核物理的工程师和物理学家。
Michael Kreindel co founded the Company in 2008 and has served as Chief Technology Officer since inception. Dr. Kreindel became a director for the Company in August 2019. He previoly was a co founder of, and served as CTO of, Syneron Medical Ltd. from 2001 to 2007. Dr. Kreindel has a Ph.D. in physics and mathematics, and also graduated as an engineer and physicist in experimental and theoretical nuclear physics from Ural Politechnical Institute, Rsia. - Michael Kreindel于2008年共同创立了该公司，并自成立以来一直担任我们的首席技术官。Kreindel博士于2019年8月成为公司董事。他曾于2001年至2007年担任Syneron MedicalLtd.的联合创始人和首席技术官。Kreindel博士拥有物理学和数学博士学位，也毕业于俄罗斯乌拉尔理工大学（Ural Politechnical Institute），担任实验和理论核物理的工程师和物理学家。
- Michael Kreindel co founded the Company in 2008 and has served as Chief Technology Officer since inception. Dr. Kreindel became a director for the Company in August 2019. He previoly was a co founder of, and served as CTO of, Syneron Medical Ltd. from 2001 to 2007. Dr. Kreindel has a Ph.D. in physics and mathematics, and also graduated as an engineer and physicist in experimental and theoretical nuclear physics from Ural Politechnical Institute, Rsia.
- Nadav Kenneth
-
Nadav Kenneth于2024年4月成为公司董事。Kenneth先生在以色列陆军情报部队（8200部队）服务了22年，在那里他领导了大型研发职能，负责战略规划部门（计划、方法、预算编制和监测），并指挥了一个情报部门。任职后，肯尼斯共同创立、管理并担任多家初创公司的董事会成员，曾任职于一家大型蜂窝运营商，并为公司和官方实体提供咨询服务。2009年，Kenneth co先生创立了QRative Ltd.，该公司开发了一个基于人工智能的知识产权分析和结晶平台，并在2009年至2022年期间担任其首席执行官和董事会成员。2007年至2011年，Kenneth先生就桑给巴尔税务局的重组以及建立政府的人力资源和工资制度向桑给巴尔政府提供了咨询。2004年，Kenneth co先生创立了Trisixty Security，该公司开发了一种自动化系统，可监控IT安全法规的遵守情况，并在2004年至2006年期间担任其国家经理和董事会成员。从2014年到2020年，Kenneth先生担任了一家职前教育非政府组织（Mechinat Aderet）的志愿者主席。Kenneth先生拥有Bar Ilan大学的经济学和政治学学士学位，以及亚特兰大/以色列斯威本大学的Biness Entrepreneurship硕士学位。
Nadav Kenneth became a director of the Company in April 2024.Mr. Kenneth served for 22 years in the Israeli Army's Intelligence corps (Unit 8200) where he led large R&D functions, was in charge of the strategic planning branch (plans, methodology, budgeting and monitoring) and commanded an intelligence unit. Following his service, Mr. Kenneth co founded, managed and served as a board member of several startup companies, worked for a large cellular operator, and provided consultation to companies and official entities. In 2009, Mr. Kenneth co founded Qrative Ltd., which developed an AI based platform for analysis and crystallization of intellectual property and served as its CEO and board member from 2009 to 2022. From 2007 to 2011, Mr. Kenneth provided consultation to the Government of Zanzibar with respect to restructuring of the Zanzibar Revenue Authority and setting up the government's HR and payroll systems. In 2004, Mr. Kenneth co founded Trisixty Security, which developed an automated system that monitored compliance with IT security regulations, and served as its country manager and board member from 2004 to 2006. From 2014 to 2020, Mr. Kenneth served as volunteer Chairman of a pre service education NGO (Mechinat Aderet). Mr. Kenneth holds a B.A. in Economics and Political Sciences from the Bar Ilan University and an M.A. in Biness Entrepreneurship from the Swinburne University in Atralia/Israel. - Nadav Kenneth于2024年4月成为公司董事。Kenneth先生在以色列陆军情报部队（8200部队）服务了22年，在那里他领导了大型研发职能，负责战略规划部门（计划、方法、预算编制和监测），并指挥了一个情报部门。任职后，肯尼斯共同创立、管理并担任多家初创公司的董事会成员，曾任职于一家大型蜂窝运营商，并为公司和官方实体提供咨询服务。2009年，Kenneth co先生创立了QRative Ltd.，该公司开发了一个基于人工智能的知识产权分析和结晶平台，并在2009年至2022年期间担任其首席执行官和董事会成员。2007年至2011年，Kenneth先生就桑给巴尔税务局的重组以及建立政府的人力资源和工资制度向桑给巴尔政府提供了咨询。2004年，Kenneth co先生创立了Trisixty Security，该公司开发了一种自动化系统，可监控IT安全法规的遵守情况，并在2004年至2006年期间担任其国家经理和董事会成员。从2014年到2020年，Kenneth先生担任了一家职前教育非政府组织（Mechinat Aderet）的志愿者主席。Kenneth先生拥有Bar Ilan大学的经济学和政治学学士学位，以及亚特兰大/以色列斯威本大学的Biness Entrepreneurship硕士学位。
- Nadav Kenneth became a director of the Company in April 2024.Mr. Kenneth served for 22 years in the Israeli Army's Intelligence corps (Unit 8200) where he led large R&D functions, was in charge of the strategic planning branch (plans, methodology, budgeting and monitoring) and commanded an intelligence unit. Following his service, Mr. Kenneth co founded, managed and served as a board member of several startup companies, worked for a large cellular operator, and provided consultation to companies and official entities. In 2009, Mr. Kenneth co founded Qrative Ltd., which developed an AI based platform for analysis and crystallization of intellectual property and served as its CEO and board member from 2009 to 2022. From 2007 to 2011, Mr. Kenneth provided consultation to the Government of Zanzibar with respect to restructuring of the Zanzibar Revenue Authority and setting up the government's HR and payroll systems. In 2004, Mr. Kenneth co founded Trisixty Security, which developed an automated system that monitored compliance with IT security regulations, and served as its country manager and board member from 2004 to 2006. From 2014 to 2020, Mr. Kenneth served as volunteer Chairman of a pre service education NGO (Mechinat Aderet). Mr. Kenneth holds a B.A. in Economics and Political Sciences from the Bar Ilan University and an M.A. in Biness Entrepreneurship from the Swinburne University in Atralia/Israel.
- Shlomo Nass
-
Shlomo Nass， 自2009年起，他担任本公司董事。他目前担任Dr. Shlomo Nass公司的高级合伙人，一家2002年12月成立，专门从事房地产、清算、接管和公司康复、仲裁、公司法及商业法的以色列律师事务所。自2011年起，他一直担任城市银行集团的City-Group金融产品以色列有限公司的董事。自2008年以来，他一直担任特拉维夫 - 荷兹利亚有限公司的Blue Shore开发公司的董事和Alron有限公司（原玉立资本市场公司）的董事。自1991年以来，他一直担任贸易征税公共咨询委员会的副主任委员。2009年至2013年，他担任投资委员会的董事和成员，担任合伙通信有限责任公司审计委员会委员。2011年至2013年，他担任天宝啤酒实业有限公司的董事和审计委员会委员。2006年至2011年，他担任美国国家气象中心娱乐有限公司的董事会成员。2003年至2010年，他担任了财务报表和公式系统-1985有限公司的审计委员会主席。2003年至2009年，他担任财务报表委员会主席和IBC-工业建筑股份有限公司的董事。2005年至2008年，他曾担任阿亚隆保险有限公司和阿亚隆金融解决方案有限公司董事会主席。他还担任下列公司的董事局主席：自2013年起， 就职于SAL Mishkenot Haretz；自2011年起，就职于Hevruta有限公司营销部和Hevruta Consumering有限公司；自2010年起，就职于 Kada 建筑公司；自2008年起，就职于Chaniman创业有限公司；自2005年起，就职于MDK触控有限公司和自2004年以来，就职于 Shir-Lak有限公司。他获得Bar-Ilan大学法律学博士学位和法学学士学位；经济学和会计的理学士学位，并完成了司法部的调解员课程。他是以色列律师协会的成员，是一名以色列的注册会计师。他也是一名注册信息系统审计师CISA（美国）。他是荷兹利亚和巴伊兰大学IDC -跨学科研究中心的公司法讲师。他也是特拉维夫大学纳蒂管理学院Lahav行政教育的董事培训研讨会的讲师。在他的兵役期间，他曾担任以色列国防军（或IDF）的人员，一个佩马斯特总局的信息系统审计队伍。
Shlomo Nass has served as a director of the Company since 2009. Dr. Nass currently serves as Senior Partner in Dr. Shlomo Nass & Co., an Israeli law firm that he founded in December 2002 specializing in real estate, liquidations, receiverships and corporate rehabilitation, arbitration, corporate and commercial law. Since 2008 he has served as a director of The Blue Shore Development Company Tel Aviv-Herzliya Ltd., and as a director of Aviv Alron Ltd. (former Yuli Capital Markets Ltd.). Since 1991 he serves as Vice Chairman of the public advisory committee on Trade Levies. From 2011 until 2014 Dr. Nass served as a director of City-Group Financial Products Israel Ltd. from City Bank Group. From 2009 until 2013 he served as a director, as a member of the investment committee and as a member of the auditing committee of Partner Communications Company Ltd. From 2011 until 2013 he served as a director and a member of the auditing committee of Tempo Beer Industries Ltd. From 2006 until 2011 he served on the Board of Directors of NMC United Entertainment Ltd. From 2003 until 2010 he served as Chairman of the financial statement and auditing committee of Formula Systems -1985 Ltd. From 2003 until 2009 he served as Chairman of the financial statement committee and as a member of the Board of Directors of IBC-Industrial Buildings Corporation Ltd. From 2005 until 2008 he served as the Chairman of the Board of Directors of Ayalon Insurance Co. Ltd. and Ayalon Financial Solutions Ltd. Dr. Nass also serves as Chairman of the Board of Directors of the following companies: since 2013 of S.A.L Mishkenot Haretz, since 2011 of Hevruta Marketing Ltd. and Hevruta Consumering Ltd., since 2010 of Kada Buildings, since 2008 of Chaniman Entrepreneurship Ltd., since 2005 of M.D.K Touch Ltd. and since 2004 of Shir-Lak Ltd. Dr. Nass received his Ph.D. and LL.B. in Law and B.Sc., Economics and Accounting from Bar-Ilan University, and completed a Mediators Course of the Ministry of Justice. He is a member of the Israeli Bar Association and is a Certified Public Accountant in Israel. Dr. Nass is also a Certified Information System Auditor, C.I.S.A (USA). Dr. Nass is a lecturer on Corporate Law at IDC - Interdisciplinary Center Herzliya, and Bar-Ilan University. He is also a lecturer in the Directors’ Training seminar at “Lahav” Executive Education at the Recanati Faculty of Management in Tel-Aviv University. - Shlomo Nass， 自2009年起，他担任本公司董事。他目前担任Dr. Shlomo Nass公司的高级合伙人，一家2002年12月成立，专门从事房地产、清算、接管和公司康复、仲裁、公司法及商业法的以色列律师事务所。自2011年起，他一直担任城市银行集团的City-Group金融产品以色列有限公司的董事。自2008年以来，他一直担任特拉维夫 - 荷兹利亚有限公司的Blue Shore开发公司的董事和Alron有限公司（原玉立资本市场公司）的董事。自1991年以来，他一直担任贸易征税公共咨询委员会的副主任委员。2009年至2013年，他担任投资委员会的董事和成员，担任合伙通信有限责任公司审计委员会委员。2011年至2013年，他担任天宝啤酒实业有限公司的董事和审计委员会委员。2006年至2011年，他担任美国国家气象中心娱乐有限公司的董事会成员。2003年至2010年，他担任了财务报表和公式系统-1985有限公司的审计委员会主席。2003年至2009年，他担任财务报表委员会主席和IBC-工业建筑股份有限公司的董事。2005年至2008年，他曾担任阿亚隆保险有限公司和阿亚隆金融解决方案有限公司董事会主席。他还担任下列公司的董事局主席：自2013年起， 就职于SAL Mishkenot Haretz；自2011年起，就职于Hevruta有限公司营销部和Hevruta Consumering有限公司；自2010年起，就职于 Kada 建筑公司；自2008年起，就职于Chaniman创业有限公司；自2005年起，就职于MDK触控有限公司和自2004年以来，就职于 Shir-Lak有限公司。他获得Bar-Ilan大学法律学博士学位和法学学士学位；经济学和会计的理学士学位，并完成了司法部的调解员课程。他是以色列律师协会的成员，是一名以色列的注册会计师。他也是一名注册信息系统审计师CISA（美国）。他是荷兹利亚和巴伊兰大学IDC -跨学科研究中心的公司法讲师。他也是特拉维夫大学纳蒂管理学院Lahav行政教育的董事培训研讨会的讲师。在他的兵役期间，他曾担任以色列国防军（或IDF）的人员，一个佩马斯特总局的信息系统审计队伍。
- Shlomo Nass has served as a director of the Company since 2009. Dr. Nass currently serves as Senior Partner in Dr. Shlomo Nass & Co., an Israeli law firm that he founded in December 2002 specializing in real estate, liquidations, receiverships and corporate rehabilitation, arbitration, corporate and commercial law. Since 2008 he has served as a director of The Blue Shore Development Company Tel Aviv-Herzliya Ltd., and as a director of Aviv Alron Ltd. (former Yuli Capital Markets Ltd.). Since 1991 he serves as Vice Chairman of the public advisory committee on Trade Levies. From 2011 until 2014 Dr. Nass served as a director of City-Group Financial Products Israel Ltd. from City Bank Group. From 2009 until 2013 he served as a director, as a member of the investment committee and as a member of the auditing committee of Partner Communications Company Ltd. From 2011 until 2013 he served as a director and a member of the auditing committee of Tempo Beer Industries Ltd. From 2006 until 2011 he served on the Board of Directors of NMC United Entertainment Ltd. From 2003 until 2010 he served as Chairman of the financial statement and auditing committee of Formula Systems -1985 Ltd. From 2003 until 2009 he served as Chairman of the financial statement committee and as a member of the Board of Directors of IBC-Industrial Buildings Corporation Ltd. From 2005 until 2008 he served as the Chairman of the Board of Directors of Ayalon Insurance Co. Ltd. and Ayalon Financial Solutions Ltd. Dr. Nass also serves as Chairman of the Board of Directors of the following companies: since 2013 of S.A.L Mishkenot Haretz, since 2011 of Hevruta Marketing Ltd. and Hevruta Consumering Ltd., since 2010 of Kada Buildings, since 2008 of Chaniman Entrepreneurship Ltd., since 2005 of M.D.K Touch Ltd. and since 2004 of Shir-Lak Ltd. Dr. Nass received his Ph.D. and LL.B. in Law and B.Sc., Economics and Accounting from Bar-Ilan University, and completed a Mediators Course of the Ministry of Justice. He is a member of the Israeli Bar Association and is a Certified Public Accountant in Israel. Dr. Nass is also a Certified Information System Auditor, C.I.S.A (USA). Dr. Nass is a lecturer on Corporate Law at IDC - Interdisciplinary Center Herzliya, and Bar-Ilan University. He is also a lecturer in the Directors’ Training seminar at “Lahav” Executive Education at the Recanati Faculty of Management in Tel-Aviv University.
高管简历
中英对照 | 中文 | 英文- Moshe Mizrahy
Moshe Mizrahy于2008年共同创立了该公司，自成立以来一直担任我们的首席执行官兼董事会主席。在此之前，Mizrahy先生是Syneron MedicalLtd.公司（一家位于以色列的医疗美容设备公司）的联合创始人兼首席执行官。Mizrahy先生也是Home Skinovations Ltd.的前首席执行官，该公司是一家活跃于家庭使用市场的国际医疗美容消费设备公司，目前自2007年起担任其董事会主席。除Home Skinovations Ltd.外，Mizrahy先生目前担任以下公司的董事会成员:Sipnose Ltd.、Pet Novations Ltd.、Peri-ness Technologies Ltd.、Easy-Lap Ltd、O.B.-Tools Ltd.、Urifer Ltd.、Easy Notes Ltd.、Escape Rescue Systems Ltd.、New Forest Wood Products-2012Ltd.，M.N.Business Strategy Ltd.、Himalaya Family Office Advisory Ltd.和Polimer Logistics Israel Ltd.Mizrahy先生在特拉维夫大学（Tel Aviv University）获得工程学学士学位，并在纽约佩斯大学（Pace University）获得工商管理硕士学位。
Moshe Mizrahy has served as a member of Xenetic Biosciences, Inc.'s Board since December 2023. Mr. Mizrahy is co founder of InMode Ltd. (NASDAQ: INMD) and has served as its Chief Executive Officer and Chairman of its board of directors since its inception in 2008. Prior to that, Mr. Mizrahy was co founder and chief executive officer of Syneron Medical Ltd. Mr. Mizrahy was also the former chief executive officer of Home Skinovations Ltd., and is currently chairman of its board. In addition to Home Skinovations Ltd., Mr. Mizrahy currently sits on the board of directors of SipNose Ltd., Pet Novations Ltd., Peri Ness Technologies Ltd., Santersus AG, Easy Lap Ltd., O.B. Tools Ltd., Urifer Ltd., Easy Notes Ltd., Escape Rescue Systems Ltd., M.N. Business Strategy Ltd., Silk'n Cure Ltd., Himalaya Family Office Advising Ltd. and Polimer Logistics (Israel) Ltd. Mr. Mizrahy is co founder and general partner of Nitzanim AVX Kyocera Venture Capital Fund and First Israel Mezzeine Investors Fund. Mr. Mizrahy has expertise in value creation for medical technologies, fundraising, public offerings, marketing and regulatory affairs. Mr. Mizrahy has a B.S. in Engineering from the Tel Aviv University and an MBA from Pace University, New York.- Moshe Mizrahy于2008年共同创立了该公司，自成立以来一直担任我们的首席执行官兼董事会主席。在此之前，Mizrahy先生是Syneron MedicalLtd.公司（一家位于以色列的医疗美容设备公司）的联合创始人兼首席执行官。Mizrahy先生也是Home Skinovations Ltd.的前首席执行官，该公司是一家活跃于家庭使用市场的国际医疗美容消费设备公司，目前自2007年起担任其董事会主席。除Home Skinovations Ltd.外，Mizrahy先生目前担任以下公司的董事会成员:Sipnose Ltd.、Pet Novations Ltd.、Peri-ness Technologies Ltd.、Easy-Lap Ltd、O.B.-Tools Ltd.、Urifer Ltd.、Easy Notes Ltd.、Escape Rescue Systems Ltd.、New Forest Wood Products-2012Ltd.，M.N.Business Strategy Ltd.、Himalaya Family Office Advisory Ltd.和Polimer Logistics Israel Ltd.Mizrahy先生在特拉维夫大学（Tel Aviv University）获得工程学学士学位，并在纽约佩斯大学（Pace University）获得工商管理硕士学位。
- Moshe Mizrahy has served as a member of Xenetic Biosciences, Inc.'s Board since December 2023. Mr. Mizrahy is co founder of InMode Ltd. (NASDAQ: INMD) and has served as its Chief Executive Officer and Chairman of its board of directors since its inception in 2008. Prior to that, Mr. Mizrahy was co founder and chief executive officer of Syneron Medical Ltd. Mr. Mizrahy was also the former chief executive officer of Home Skinovations Ltd., and is currently chairman of its board. In addition to Home Skinovations Ltd., Mr. Mizrahy currently sits on the board of directors of SipNose Ltd., Pet Novations Ltd., Peri Ness Technologies Ltd., Santersus AG, Easy Lap Ltd., O.B. Tools Ltd., Urifer Ltd., Easy Notes Ltd., Escape Rescue Systems Ltd., M.N. Business Strategy Ltd., Silk'n Cure Ltd., Himalaya Family Office Advising Ltd. and Polimer Logistics (Israel) Ltd. Mr. Mizrahy is co founder and general partner of Nitzanim AVX Kyocera Venture Capital Fund and First Israel Mezzeine Investors Fund. Mr. Mizrahy has expertise in value creation for medical technologies, fundraising, public offerings, marketing and regulatory affairs. Mr. Mizrahy has a B.S. in Engineering from the Tel Aviv University and an MBA from Pace University, New York.
- Michael Kreindel
Michael Kreindel于2008年共同创立了该公司，并自成立以来一直担任我们的首席技术官。Kreindel博士于2019年8月成为公司董事。他曾于2001年至2007年担任Syneron MedicalLtd.的联合创始人和首席技术官。Kreindel博士拥有物理学和数学博士学位，也毕业于俄罗斯乌拉尔理工大学（Ural Politechnical Institute），担任实验和理论核物理的工程师和物理学家。
Michael Kreindel co founded the Company in 2008 and has served as Chief Technology Officer since inception. Dr. Kreindel became a director for the Company in August 2019. He previoly was a co founder of, and served as CTO of, Syneron Medical Ltd. from 2001 to 2007. Dr. Kreindel has a Ph.D. in physics and mathematics, and also graduated as an engineer and physicist in experimental and theoretical nuclear physics from Ural Politechnical Institute, Rsia.- Michael Kreindel于2008年共同创立了该公司，并自成立以来一直担任我们的首席技术官。Kreindel博士于2019年8月成为公司董事。他曾于2001年至2007年担任Syneron MedicalLtd.的联合创始人和首席技术官。Kreindel博士拥有物理学和数学博士学位，也毕业于俄罗斯乌拉尔理工大学（Ural Politechnical Institute），担任实验和理论核物理的工程师和物理学家。
- Michael Kreindel co founded the Company in 2008 and has served as Chief Technology Officer since inception. Dr. Kreindel became a director for the Company in August 2019. He previoly was a co founder of, and served as CTO of, Syneron Medical Ltd. from 2001 to 2007. Dr. Kreindel has a Ph.D. in physics and mathematics, and also graduated as an engineer and physicist in experimental and theoretical nuclear physics from Ural Politechnical Institute, Rsia.
- Michael Dennison
迈克尔·丹尼森自2025年9月起担任新任命的北美总裁。在担任之前的职务时，Dennison先生曾在公司担任多个职位，包括2018年至2022年的销售经理、2022年至2024年的区域经理以及2024年至2025年的副总裁。丹尼森先生拥有伊利湖拼贴画公司的Biness学位。
Michael Dennison serves as newly appointed President of North America since September 2025. In his previo roles, Mr. Dennison served in several positions in the Company, including as a sales manager from 2018 to 2022, regional manager from 2022 to 2024, and vice president from 2024 to 2025. Mr. Dennison holds a degree in Biness from Lake Erie Collage.- 迈克尔·丹尼森自2025年9月起担任新任命的北美总裁。在担任之前的职务时，Dennison先生曾在公司担任多个职位，包括2018年至2022年的销售经理、2022年至2024年的区域经理以及2024年至2025年的副总裁。丹尼森先生拥有伊利湖拼贴画公司的Biness学位。
- Michael Dennison serves as newly appointed President of North America since September 2025. In his previo roles, Mr. Dennison served in several positions in the Company, including as a sales manager from 2018 to 2022, regional manager from 2022 to 2024, and vice president from 2024 to 2025. Mr. Dennison holds a degree in Biness from Lake Erie Collage.
- Moshe Itzkovich
Moshe Itzkovich，此前自2026年1月起担任公司北美和欧洲财务高级副总裁。在此之前，Itzkovich先生曾担任公司及其某些全资子公司的各种职务，包括在2022年1月至2025年12月期间担任北美财务副总裁。2018年8月至2021年12月，Itzkovich先生担任Home Skinovations Ltd.财务副总裁。Itzkovich先生还是公司加拿大子公司Invasix Corp.的董事会成员。Itzkovich先生拥有特拉维夫大学会计和经济学学位。
Moshe Itzkovich,previously served as the Company's Senior Vice President, Finance, for North America and Europe since January 2026. Prior to that, Mr. Itzkovich served the Company and certain of its wholly owned subsidiaries in various roles, including as Vice President of Finance, North America from January 2022 to December 2025. From August 2018 to December 2021, Mr. Itzkovich served as the Vice President of Finance of Home Skinovations Ltd. Mr. Itzkovich is also a member of the board of directors of the Company's Canadian subsidiary, Invasix Corp. Mr. Itzkovich holds a degree in Accounting and Economics from Tel Aviv University.- Moshe Itzkovich，此前自2026年1月起担任公司北美和欧洲财务高级副总裁。在此之前，Itzkovich先生曾担任公司及其某些全资子公司的各种职务，包括在2022年1月至2025年12月期间担任北美财务副总裁。2018年8月至2021年12月，Itzkovich先生担任Home Skinovations Ltd.财务副总裁。Itzkovich先生还是公司加拿大子公司Invasix Corp.的董事会成员。Itzkovich先生拥有特拉维夫大学会计和经济学学位。
- Moshe Itzkovich,previously served as the Company's Senior Vice President, Finance, for North America and Europe since January 2026. Prior to that, Mr. Itzkovich served the Company and certain of its wholly owned subsidiaries in various roles, including as Vice President of Finance, North America from January 2022 to December 2025. From August 2018 to December 2021, Mr. Itzkovich served as the Vice President of Finance of Home Skinovations Ltd. Mr. Itzkovich is also a member of the board of directors of the Company's Canadian subsidiary, Invasix Corp. Mr. Itzkovich holds a degree in Accounting and Economics from Tel Aviv University.